Clinical Trials Browser

Phase 2 × Completed × becatecarin × Clear all

Neuroblastoma

NCT00005027 2013-04-05

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

Phase 2 Completed

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00005085 2013-02-11

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Phase 2 Completed

37 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00006102 2013-02-05

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Phase 2 Completed

200 enrolled

CNSLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Neuroblastoma, Oligodendroglioma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

NCT00005817 2013-02-01

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Phase 2 Completed

42 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00006017 2010-06-10

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

Phase 2 Completed

42 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer